MDT - Medtronic plc


86.65
0.910   1.050%

Share volume: 6,995,306
Last Updated: 03-31-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.13%

PREVIOUS CLOSE
CHG
CHG%

$85.74
0.91
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
45%
Profitability 41%
Dept financing 19%
Liquidity 25%
Performance 61%
Company vs Stock growth
vs
Performance
5 Days
-0.56%
1 Month
-11.67%
3 Months
-9.79%
6 Months
-8.61%
1 Year
-2.08%
2 Year
-0.43%
Key data
Stock price
$86.65
P/E Ratio 
28.04
DAY RANGE
$84.92 - $86.78
EPS 
$3.59
52 WEEK RANGE
$79.55 - $106.33
52 WEEK CHANGE
-$2.49
MARKET CAP 
129.330 B
YIELD 
2.81%
SHARES OUTSTANDING 
1.284 B
DIVIDEND
$0.71
EX-DIVIDEND DATE
03-27-2026
NEXT EARNINGS DATE
08-19-2025
BETA 
0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$8,539,109
AVERAGE 30 VOLUME 
$8,386,846
Company detail
CEO: Geoffrey S. Martha
Region: US
Website: medtronic.com
Employees: 95,000
IPO year: 1981
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.

Recent news